Cargando…
Current Targeted Therapies for the Fight against Non-Small Cell Lung Cancer
Lung cancers contribute to the greatest number of cancer-related deaths worldwide and still pose challenges in response to current treatment strategies. Non-small cell lung cancer (NSCLC) accounts for over 85% of lung cancers diagnosed in the United States and novel therapeutics are needed for the t...
Autores principales: | Mustachio, Lisa Maria, Roszik, Jason |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695293/ https://www.ncbi.nlm.nih.gov/pubmed/33182254 http://dx.doi.org/10.3390/ph13110374 |
Ejemplares similares
-
Single-Cell Sequencing: Current Applications in Precision Onco-Genomics and Cancer Therapeutics
por: Mustachio, Lisa Maria, et al.
Publicado: (2022) -
Opportunities for Single-Cell Sequencing Technologies and Data Science
por: Mustachio, Lisa Maria, et al.
Publicado: (2020) -
Targeting KRAS in Cancer: Promising Therapeutic Strategies
por: Mustachio, Lisa Maria, et al.
Publicado: (2021) -
Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma
por: Roszik, Jason, et al.
Publicado: (2021) -
Biomarker-Targeted Therapies in Non–Small Cell Lung Cancer: Current Status and Perspectives
por: Guo, Haiyang, et al.
Publicado: (2022)